Fotemustine plus dacarbazine for malignant melanoma
Identifieur interne : 000844 ( Istex/Curation ); précédent : 000843; suivant : 000845Fotemustine plus dacarbazine for malignant melanoma
Auteurs : Marie-F Avril [France] ; Jean Bonneterre [France] ; Didier Cupissol [France] ; Jean-J Grob [France] ; Bernard Kalis [France] ; Pierre Fumoleau [France] ; Pierre Kerbrat [France] ; Lucien Israel [France] ; Pierre Fargeot [France] ; Daniel Lambert [France] ; Michelle Delaunay [France] ; Brigitte Dreno [France] ; Catherine Vilmer [France] ; Jean-P Bizzari [France] ; Véronique Cour [France]Source :
- European Journal of Cancer [ 0959-8049 ] ; 1992.
English descriptors
- Teeft :
- Alkaline phosphatases, Biometric parameters, Cancer chemother, Centre, Cerebral lesions, Cerebral metastases, Chemotherapy, Clinical trials, Combination chemotherapy, Complete response, Complete responses, Dacarbazine, Disease progression, Dominant metastatic site, Early death, Eurj cancer, Evaluable, Evaluable patients, Final evaluation, Fotemustine, Grade leukopenia, Haematological, Haematological toxicity, High performance, Hopital, Induction cycle, Lesion, Limb perfusion, Maintenance cycle, Malignant, Malignant melanoma, Median, Median days, Median duration, Median durations, Median nadir, Median survival time, Melanoma, Melphalan, Metastasis, Metastatic, Metastatic melanoma, Monotherapy, Natural history, Objective responses, Overall response rate, Partial response, Partial responses, Present series, Prognostic factors, Regimen, Response range, Response rate, Response rates, Toxicity, Visceral lesions, Visceral metastases.
Abstract
Abstract: 119 patients with metastatic melanoma received fotemustine 100 mg/m2 on days 1 and 8 and dacarbazine 250 mg/m2 on days 15–18. After a 5-week rest, fotemustine 100 mg/m2 on day 1 and dacarbazine 250 mg/m2 on days 2–5 was given every 3–4 weeks. 12 complete responses (11.6%) and 16 partial responses were observed in 103 evaluable patients (response rate 27.2%). The median duration of response was 21.5+ weeks (8+ to 53+). The response rate was 26.3% in CNS, 18.2% in visceral sites and 37.5% in non-visceral sites. The toxicity was mainly haematological: grade III–IV leukopenia in 27.4% and thrombocytopenia in 23.4%. The response rate was lower than that in 63 patients previously reported. The present series had a higher median age (54 vs. 40 years) without any differences in other population variables. However, activity on CNS metastases and on non-visceral sites was confirmed. Haematological toxicity was about 50% lower than that with fotemustine alone. Hence, this is an active outpatient regiment for metastatic melanoma, especially against cerebral and non-visceral metastases.
Url:
DOI: 10.1016/0959-8049(92)90008-P
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000845
Links to Exploration step
ISTEX:5FBA56325E17E2F1F107DCCE3C6131B8BF9E9A24Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Fotemustine plus dacarbazine for malignant melanoma</title>
<author><name sortKey="Avril, Marie F" sort="Avril, Marie F" uniqKey="Avril M" first="Marie-F" last="Avril">Marie-F Avril</name>
<affiliation wicri:level="1"><mods:affiliation>Institut Gustave Roussy, Service de Dermatologie, 39, rue Camille Desmoulins, 94805 Villejuif Cedex, France</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut Gustave Roussy, Service de Dermatologie, 39, rue Camille Desmoulins, 94805 Villejuif Cedex</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Bonneterre, Jean" sort="Bonneterre, Jean" uniqKey="Bonneterre J" first="Jean" last="Bonneterre">Jean Bonneterre</name>
<affiliation wicri:level="1"><mods:affiliation>Centre Oscar Lambret, Lille, France</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Centre Oscar Lambret, Lille</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Cupissol, Didier" sort="Cupissol, Didier" uniqKey="Cupissol D" first="Didier" last="Cupissol">Didier Cupissol</name>
<affiliation wicri:level="1"><mods:affiliation>Centre Val d'Aurelle, Montpellier, France</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Centre Val d'Aurelle, Montpellier</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Grob, Jean J" sort="Grob, Jean J" uniqKey="Grob J" first="Jean-J" last="Grob">Jean-J Grob</name>
<affiliation wicri:level="1"><mods:affiliation>Hôpital Sainte-Marguerite, Marseille, France</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Hôpital Sainte-Marguerite, Marseille</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Kalis, Bernard" sort="Kalis, Bernard" uniqKey="Kalis B" first="Bernard" last="Kalis">Bernard Kalis</name>
<affiliation wicri:level="1"><mods:affiliation>Hôpital Sébastopol, Reims, France</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Hôpital Sébastopol, Reims</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Fumoleau, Pierre" sort="Fumoleau, Pierre" uniqKey="Fumoleau P" first="Pierre" last="Fumoleau">Pierre Fumoleau</name>
<affiliation wicri:level="1"><mods:affiliation>Centre René Gauducheau, Nantes, France</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Centre René Gauducheau, Nantes</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Kerbrat, Pierre" sort="Kerbrat, Pierre" uniqKey="Kerbrat P" first="Pierre" last="Kerbrat">Pierre Kerbrat</name>
<affiliation wicri:level="1"><mods:affiliation>Centre Eugène Marquis, Rennes, France</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Centre Eugène Marquis, Rennes</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Israel, Lucien" sort="Israel, Lucien" uniqKey="Israel L" first="Lucien" last="Israel">Lucien Israel</name>
<affiliation wicri:level="1"><mods:affiliation>Hôpital Avicenne, Bobigny, France</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Hôpital Avicenne, Bobigny</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Fargeot, Pierre" sort="Fargeot, Pierre" uniqKey="Fargeot P" first="Pierre" last="Fargeot">Pierre Fargeot</name>
<affiliation wicri:level="1"><mods:affiliation>Centre Georges François Leclerc, Dijon, France</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Centre Georges François Leclerc, Dijon</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Lambert, Daniel" sort="Lambert, Daniel" uniqKey="Lambert D" first="Daniel" last="Lambert">Daniel Lambert</name>
<affiliation wicri:level="1"><mods:affiliation>C.H.R.U.—Hôpital du bocage, Dijon, France</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>C.H.R.U.—Hôpital du bocage, Dijon</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Delaunay, Michelle" sort="Delaunay, Michelle" uniqKey="Delaunay M" first="Michelle" last="Delaunay">Michelle Delaunay</name>
<affiliation wicri:level="1"><mods:affiliation>Hôpital Pellegrin Tripode, Bordeaux, France</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Hôpital Pellegrin Tripode, Bordeaux</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Dreno, Brigitte" sort="Dreno, Brigitte" uniqKey="Dreno B" first="Brigitte" last="Dreno">Brigitte Dreno</name>
<affiliation wicri:level="1"><mods:affiliation>C.H.U. Hotel-Dieu, Nantes, France</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>C.H.U. Hotel-Dieu, Nantes</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Vilmer, Catherine" sort="Vilmer, Catherine" uniqKey="Vilmer C" first="Catherine" last="Vilmer">Catherine Vilmer</name>
<affiliation wicri:level="1"><mods:affiliation>Centre René Huguenin, Saint-Cloud, France</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Centre René Huguenin, Saint-Cloud</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Bizzari, Jean P" sort="Bizzari, Jean P" uniqKey="Bizzari J" first="Jean-P" last="Bizzari">Jean-P Bizzari</name>
<affiliation wicri:level="1"><mods:affiliation>Institut de Recherches Internationales Servier, Courbevoie, France</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut de Recherches Internationales Servier, Courbevoie</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Cour, Veronique" sort="Cour, Veronique" uniqKey="Cour V" first="Véronique" last="Cour">Véronique Cour</name>
<affiliation wicri:level="1"><mods:affiliation>Institut de Recherches Internationales Servier, Courbevoie, France</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut de Recherches Internationales Servier, Courbevoie</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:5FBA56325E17E2F1F107DCCE3C6131B8BF9E9A24</idno>
<date when="1992" year="1992">1992</date>
<idno type="doi">10.1016/0959-8049(92)90008-P</idno>
<idno type="url">https://api.istex.fr/document/5FBA56325E17E2F1F107DCCE3C6131B8BF9E9A24/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000845</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000845</idno>
<idno type="wicri:Area/Istex/Curation">000844</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a">Fotemustine plus dacarbazine for malignant melanoma</title>
<author><name sortKey="Avril, Marie F" sort="Avril, Marie F" uniqKey="Avril M" first="Marie-F" last="Avril">Marie-F Avril</name>
<affiliation wicri:level="1"><mods:affiliation>Institut Gustave Roussy, Service de Dermatologie, 39, rue Camille Desmoulins, 94805 Villejuif Cedex, France</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut Gustave Roussy, Service de Dermatologie, 39, rue Camille Desmoulins, 94805 Villejuif Cedex</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Bonneterre, Jean" sort="Bonneterre, Jean" uniqKey="Bonneterre J" first="Jean" last="Bonneterre">Jean Bonneterre</name>
<affiliation wicri:level="1"><mods:affiliation>Centre Oscar Lambret, Lille, France</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Centre Oscar Lambret, Lille</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Cupissol, Didier" sort="Cupissol, Didier" uniqKey="Cupissol D" first="Didier" last="Cupissol">Didier Cupissol</name>
<affiliation wicri:level="1"><mods:affiliation>Centre Val d'Aurelle, Montpellier, France</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Centre Val d'Aurelle, Montpellier</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Grob, Jean J" sort="Grob, Jean J" uniqKey="Grob J" first="Jean-J" last="Grob">Jean-J Grob</name>
<affiliation wicri:level="1"><mods:affiliation>Hôpital Sainte-Marguerite, Marseille, France</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Hôpital Sainte-Marguerite, Marseille</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Kalis, Bernard" sort="Kalis, Bernard" uniqKey="Kalis B" first="Bernard" last="Kalis">Bernard Kalis</name>
<affiliation wicri:level="1"><mods:affiliation>Hôpital Sébastopol, Reims, France</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Hôpital Sébastopol, Reims</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Fumoleau, Pierre" sort="Fumoleau, Pierre" uniqKey="Fumoleau P" first="Pierre" last="Fumoleau">Pierre Fumoleau</name>
<affiliation wicri:level="1"><mods:affiliation>Centre René Gauducheau, Nantes, France</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Centre René Gauducheau, Nantes</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Kerbrat, Pierre" sort="Kerbrat, Pierre" uniqKey="Kerbrat P" first="Pierre" last="Kerbrat">Pierre Kerbrat</name>
<affiliation wicri:level="1"><mods:affiliation>Centre Eugène Marquis, Rennes, France</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Centre Eugène Marquis, Rennes</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Israel, Lucien" sort="Israel, Lucien" uniqKey="Israel L" first="Lucien" last="Israel">Lucien Israel</name>
<affiliation wicri:level="1"><mods:affiliation>Hôpital Avicenne, Bobigny, France</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Hôpital Avicenne, Bobigny</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Fargeot, Pierre" sort="Fargeot, Pierre" uniqKey="Fargeot P" first="Pierre" last="Fargeot">Pierre Fargeot</name>
<affiliation wicri:level="1"><mods:affiliation>Centre Georges François Leclerc, Dijon, France</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Centre Georges François Leclerc, Dijon</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Lambert, Daniel" sort="Lambert, Daniel" uniqKey="Lambert D" first="Daniel" last="Lambert">Daniel Lambert</name>
<affiliation wicri:level="1"><mods:affiliation>C.H.R.U.—Hôpital du bocage, Dijon, France</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>C.H.R.U.—Hôpital du bocage, Dijon</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Delaunay, Michelle" sort="Delaunay, Michelle" uniqKey="Delaunay M" first="Michelle" last="Delaunay">Michelle Delaunay</name>
<affiliation wicri:level="1"><mods:affiliation>Hôpital Pellegrin Tripode, Bordeaux, France</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Hôpital Pellegrin Tripode, Bordeaux</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Dreno, Brigitte" sort="Dreno, Brigitte" uniqKey="Dreno B" first="Brigitte" last="Dreno">Brigitte Dreno</name>
<affiliation wicri:level="1"><mods:affiliation>C.H.U. Hotel-Dieu, Nantes, France</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>C.H.U. Hotel-Dieu, Nantes</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Vilmer, Catherine" sort="Vilmer, Catherine" uniqKey="Vilmer C" first="Catherine" last="Vilmer">Catherine Vilmer</name>
<affiliation wicri:level="1"><mods:affiliation>Centre René Huguenin, Saint-Cloud, France</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Centre René Huguenin, Saint-Cloud</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Bizzari, Jean P" sort="Bizzari, Jean P" uniqKey="Bizzari J" first="Jean-P" last="Bizzari">Jean-P Bizzari</name>
<affiliation wicri:level="1"><mods:affiliation>Institut de Recherches Internationales Servier, Courbevoie, France</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut de Recherches Internationales Servier, Courbevoie</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Cour, Veronique" sort="Cour, Veronique" uniqKey="Cour V" first="Véronique" last="Cour">Véronique Cour</name>
<affiliation wicri:level="1"><mods:affiliation>Institut de Recherches Internationales Servier, Courbevoie, France</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut de Recherches Internationales Servier, Courbevoie</wicri:regionArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">European Journal of Cancer</title>
<title level="j" type="abbrev">EJC</title>
<idno type="ISSN">0959-8049</idno>
<imprint><publisher>ELSEVIER</publisher>
<date type="published" when="1992">1992</date>
<biblScope unit="volume">28</biblScope>
<biblScope unit="issue">11</biblScope>
<biblScope unit="page" from="1807">1807</biblScope>
<biblScope unit="page" to="1811">1811</biblScope>
</imprint>
<idno type="ISSN">0959-8049</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0959-8049</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Alkaline phosphatases</term>
<term>Biometric parameters</term>
<term>Cancer chemother</term>
<term>Centre</term>
<term>Cerebral lesions</term>
<term>Cerebral metastases</term>
<term>Chemotherapy</term>
<term>Clinical trials</term>
<term>Combination chemotherapy</term>
<term>Complete response</term>
<term>Complete responses</term>
<term>Dacarbazine</term>
<term>Disease progression</term>
<term>Dominant metastatic site</term>
<term>Early death</term>
<term>Eurj cancer</term>
<term>Evaluable</term>
<term>Evaluable patients</term>
<term>Final evaluation</term>
<term>Fotemustine</term>
<term>Grade leukopenia</term>
<term>Haematological</term>
<term>Haematological toxicity</term>
<term>High performance</term>
<term>Hopital</term>
<term>Induction cycle</term>
<term>Lesion</term>
<term>Limb perfusion</term>
<term>Maintenance cycle</term>
<term>Malignant</term>
<term>Malignant melanoma</term>
<term>Median</term>
<term>Median days</term>
<term>Median duration</term>
<term>Median durations</term>
<term>Median nadir</term>
<term>Median survival time</term>
<term>Melanoma</term>
<term>Melphalan</term>
<term>Metastasis</term>
<term>Metastatic</term>
<term>Metastatic melanoma</term>
<term>Monotherapy</term>
<term>Natural history</term>
<term>Objective responses</term>
<term>Overall response rate</term>
<term>Partial response</term>
<term>Partial responses</term>
<term>Present series</term>
<term>Prognostic factors</term>
<term>Regimen</term>
<term>Response range</term>
<term>Response rate</term>
<term>Response rates</term>
<term>Toxicity</term>
<term>Visceral lesions</term>
<term>Visceral metastases</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Abstract: 119 patients with metastatic melanoma received fotemustine 100 mg/m2 on days 1 and 8 and dacarbazine 250 mg/m2 on days 15–18. After a 5-week rest, fotemustine 100 mg/m2 on day 1 and dacarbazine 250 mg/m2 on days 2–5 was given every 3–4 weeks. 12 complete responses (11.6%) and 16 partial responses were observed in 103 evaluable patients (response rate 27.2%). The median duration of response was 21.5+ weeks (8+ to 53+). The response rate was 26.3% in CNS, 18.2% in visceral sites and 37.5% in non-visceral sites. The toxicity was mainly haematological: grade III–IV leukopenia in 27.4% and thrombocytopenia in 23.4%. The response rate was lower than that in 63 patients previously reported. The present series had a higher median age (54 vs. 40 years) without any differences in other population variables. However, activity on CNS metastases and on non-visceral sites was confirmed. Haematological toxicity was about 50% lower than that with fotemustine alone. Hence, this is an active outpatient regiment for metastatic melanoma, especially against cerebral and non-visceral metastases.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Psychologie/explor/BernheimV1/Data/Istex/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000844 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 000844 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Psychologie |area= BernheimV1 |flux= Istex |étape= Curation |type= RBID |clé= ISTEX:5FBA56325E17E2F1F107DCCE3C6131B8BF9E9A24 |texte= Fotemustine plus dacarbazine for malignant melanoma }}
This area was generated with Dilib version V0.6.33. |